infigratinib,niraparib
bridgebio pharmaceutical
['niraparib', 'infigratinib']
having an exciting time at #asco23! the ivy center showcased groundbreaking research with two posters on phase 0 trials of infigratinib and niraparib in recurrent high-grade glioma and newly-diagnosed #glioblastoma. next stop boston for #bio2023. stay tuned for updates! 
Largest #Phase0 clinical trials program in the world providing personalized treatment options for patients with #glioblastoma & other aggressive brain tumors.